Clinical Trials in Colorado

Showing 5621-5640 of 13,761 trials

Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain

NCT05470608

This is a multicenter, randomized, double-blind, placebo-controlled, single ascending dose escalation study to assess the safety and efficacy of single treatment exposure of an injectable formulation of SL-1002 for the treatment of knee pain associated with osteoarthritis. Phase A of the study will enroll 3 cohorts of 8 patients per cohort, for a total of 24 patients. Patients will be randomized to receive either SL-1002 or placebo in a 3:1 ratio within each given cohort. Phase B of the study will enroll a minimum of 92 up to a maximum of 108 patients. Patients will be randomized to receive either SL-1002 or placebo in a 3:1 ratio at the recommended dose determined from Phase A. The study period will be up to 168 days inclusive of a screening period of up to 28 days.

Osteoarthritis, Knee Pain

Saol Therapeutics Inc132 participantsStarted Jun 2022

Greenwood Village, Colorado, United States • Washington D.C., District of Columbia, United States • Coral Gables, Florida, United States +12 more locations

COMPLETEDPhase 346 miles

A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma

NCT05042609

The primary objective of this study is to evaluate the efficacy and safety of TRS01 eye drops compared to active comparator in subjects with active non-infectious anterior uveitis with or without uveitic glaucoma

Non-infectious Anterior UveitisUveitic Glaucoma

Tarsier Pharma142 participantsStarted Sep 2021

La Jolla, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +27 more locations

Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain

A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma

Find Trials by Condition in Colorado

A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM)

Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease

A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma

A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy

Study of Sargramostim in Patients With COVID-19

Maximizing Outcomes in Treating Acute Migraine

Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

Safety and Tolerability of Repeat Courses of IM Alefacept

Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants

Investigation of Novel Surgical Imaging for Tumor Excision

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)

Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study

Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma

BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome

AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)

Phase 2 Clinical Trial of CartiLife® in the United States

Resynchronization/Defibrillation for Ambulatory Heart Failure Trial